by Cort Johnson | Aug 17, 2018 | Clonidine, Homepage, Ivabradine, Mast cell activation syndrome, POTS, Propanolol
Italo Biaggioni, a respected Vanderbilt researcher in the field, has co-authored 100’s of studies on dysautonomia. He was an impressive speaker, at ease and relaxed in front of the room. I felt like I was sitting in his living room. He noted that the... 
by Cort Johnson | Aug 15, 2018 | Antiphospholipid Antibody Syndrome, Antiphospholipid Antibody Syndrome, Autoimmune, Autonomic Nervous System, Heparin, Homepage, POTS
This blog is part IV in a series of blogs covering the issues presented at the 2018 Dysautonomia International Conference in Nashville, Tennessee. As if we needed another syndrome. Chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),... 
by Cort Johnson | Aug 13, 2018 | Autoimmune, Homepage, Immune, IVIG
Thinking Outside the Box This is the second of three posts on IVIG treatment and autoimmunity in chronic fatigue syndrome (ME/CFS), POTS and fibromyalgia. It’s time to start thinking outside the traditional ME/CFS/POTS/FM boxes. It’s possible that if you’ve... 
by Cort Johnson | Aug 11, 2018 | Autoimmune, Homepage, IVIG, POTS
Suzi’s story is the first in a series of blogs exploring the possibility that the autoimmune findings will open the door for IVIG (Intravenous Immunoglobulin) treatment in chronic fatigue syndrome (ME/CFS), fibromaylgia (FM) and postural orthostatic tachycardia... 
by Cort Johnson | Apr 20, 2018 | Fibromyalgia and Pain, Genetics, Homepage, Opioid drugs, Research
From Dr. Trescott’s lecture given to the Physician Partners of America: “Your Genes, Your Pain Drugs and You Or “Why Every Pain Physician Should be Testing Your Genes“ When the patient says, “This doesn’t work,” or, “I’ve been too sensitive,”... 
by Cort Johnson | Nov 26, 2017 | Rituximab, Treatment
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research fund – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
